Genomic data of metastatic PCa from the MSKCC study [27] showed approximately 78% of the patients showing alterations in the PI3K/Akt pathway genes, with the majority of 42% of the alterations found as the PTEN gene deletion, fusion or loss of function mutations. Here, AKT1 is linked to posterior cortical atrophy.